摘要
目的分析二冬琼玉汤加减辅助治疗初期肺结核的临床效果。方法将100例初期肺结核患者依据治疗方法的不同分为常规治疗组(n=50,常规抗结核治疗)和辅助治疗组(n=50,二冬琼玉汤加减辅助常规抗结核治疗),比较两组的治疗效果。结果治疗1、3个月后,辅助治疗组的痰菌阴转率、病灶吸收率均高于常规治疗组(P<0.05)。辅助治疗组的治疗总有效率高于常规治疗组(P<0.05)。治疗后,辅助治疗组的CD3^+、CD4^+及CD4^+/CD8^+水平均高于常规治疗组(P<0.05)。结论二冬琼玉汤加减辅助治疗初期肺结核的临床效果显著。
Objective To analyze the clinical effect of modified Erdong Qiongyu decoction in adjuvant treatment of pulmonary tuberculosis at the initial stage.Methods A total of 100 patients with pulmonary tuberculosis at the initial stage were divided into routine treatment group(n=50,routine anti-tuberculosis treatment)and adjuvant treatment group(n=50,modified Erdong Qiongyu decoction adjuvant routine anti-tuberculosis treatment)according to different treatment methods,and the therapeutic effects of the two groups were compared.Results At 1 and 3 months after treatment,the sputum negative conversion rate and lesion absorption rate of the adjuvant treatment group were higher than those of the routine treatment group(P<0.05).The total effective rate of treatment in the adjuvant treatment group was higher than that in the routine treatment group(P<0.05).After treatment,the levels of CD3^+,CD4^+and CD4^+/CD8^+in the adjuvant treatment group were higher than those in the routine treatment group(P<0.05).Conclusion The clinical effect of modified Erdong Qiongyu decoction in adjuvant treatment of pulmonary tuberculosis at the initial stage is significant.
作者
张卫涛
ZHANG Weitao(Zhoukou Infectious Diseases Hospital,Zhoukou 466000,China)
出处
《临床医学研究与实践》
2020年第22期123-124,共2页
Clinical Research and Practice
关键词
肺结核
二冬琼玉汤
痰菌阴转
pulmonary tuberculosis
Erdong Qiongyu decoction
sputum negative conversion
